Work

Safety of Subcutaneous Daratumumab/ Hyaluronidase after Intravenous Daratumumab for Patients with Multiple Myeloma

Year: 2022

Type: article

Study design: Observational Study

Source: Blood

DOI: 10.1182/blood-2022-162665

Authors: Melissa Copley, Leland Metheny, Rebecca B. Klisovic, Ehsan Malek

Institutions: University Hospitals Seidman Cancer Center, University Hospitals Cleveland Medical Center

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4310120152

FWCI: 0.156

Cites:

Cited by: 1

Related to: 10